Skip to main content
. 2019 Sep 4;9(9):223. doi: 10.3390/brainsci9090223

Figure 3.

Figure 3

Effect of trimester of disease duration at PEG placement on remaining disease duration. Each of the PEG users’ disease durations was divided into three equal time periods, called trimesters. (A) Patients who began PEG in the first trimester (n = 116) did not have significantly different disease durations than those who began PEG in the second trimester (n = 87) (p > 0.05). (B) Patients who began PEG in the second trimester (n = 87) did not have significantly different disease durations than patients in the third trimester (n = 53) (p > 0.05). (C) Patients who began PEG in the first trimester (n = 116) did not have significantly different disease durations than those who began PEG in the third trimester (n = 53) (p > 0.05).